(Q72533997)
Statements
[Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies] (English)
K Ota
R Ohno
S Shirakawa
T Masaoka
K Okada
Y Ohashi